FOOTNOTE: EPD DAILY ACTIVITY REPORT information was provided by the EPD and posted by the City-County-County Observer without opinion, bias, or editing.
FOOTNOTE: EPD DAILY ACTIVITY REPORT information was provided by the EPD and posted by the City-County-County Observer without opinion, bias, or editing.
IMPRACTCAL JOKER SAL VULCANO BRINGS
EVERYTHING IS FINE TOUR TO EVANSVILLE
TICKETS GO ON SALE NATIONALLY ON FRIDAY, MAY 31, AT 10 AM
Evansville, IN – May 28, 2024 – Comedian and television personality, Sal Vulcano, announced today his
Everything is Fine Tour will stop at Old National Events Plaza on January 17, 2025. Vulcano is best known for his
improvisational skills and acting in the hit TV show ‘Impractical Jokers,
” an American hidden camera comedy and
reality show with improvisational elements.
Hailing from Staten Island, Sal Vulcano is a household name in the world of comedy. As a founding member of
“The Tenderloins Comedy Troupe,
” alongside James Murray, Brian Quinn, and Joe Gatto, Vulcano has captivated
audiences with his unique brand of humor. Together, The Tenderloins have amused fans since 2011.
Jokers’ tenth season premiered in early 2023 and has continued to delight viewers with its hilarious antics. The
show’s intro describes it as “scenes of graphic stupidity among (four) lifelong friends who compete to embarrass
each other.” Featuring themes that rely heavily on improvisation and slapstick routines, the show garners
laughable reactions from both the jokers and the members of the public.
Beyond the small screen, Sal Vulcano has carved out a niche for himself in stand-up comedy, earning great
reviews for performances that blend observational humor with personal anecdotes. Vulcano has also co-hosted
popular podcasts such as “Hey Babe!” and “What Say You?” alongside fellow comedians. With his Everything is
Fine Tour, Vulcano promises an evening of side-splitting comedy and genuine entertainment that will leave
audiences rolling in the aisles.
Ticket Information:
What: Sal Vulcano: Everything is Fine Tour
When: Friday, January 17, 2025, at 7:00 PM
Where: Old National Events Plaza | 715 Locust Street | Evansville, IN 47708
Tickets: Tickets start at $35.75 plus applicable fees and tax.
Tickets are available at Ticketmaster.com or the Old National Events Plaza Box Office.
For more information about the Aiken Theatre, visit: www.oldnationaleventsplaza.com.
-more-About Outback Presents
Outback Presents is the leading independent, full-service promoter of live entertainment. From their home base
in Nashville, TN, Outback Presents specializes in producing music and comedy shows, tours and festivals across
North America and connecting their diverse roster of artists with their fans. For more information, visit
www.outbackpresents.com.
About Old National Events Plaza
Old National Events Plaza, managed by ASM Global, is Evansville, Indiana’s premier convention center and
largest live entertainment theatre. Housing a spacious 2,500-seat theatre, 38,000 square- feet of column free
exhibit space, a beautiful 14,000 square-foot ballroom, and 12,00 square-feet of meeting space, Old National
Events Plaza hosts a variety of events. The venue offers easy scheduling, one-stop-shop services, and in-house
catering and audio-visual services. For more information and a complete schedule of events, please visit
www.oldnationaleventsplaza.com.
About ASM Global
ASM Global is the world’s leading producer of entertainment experiences. It is the global leader in venue and
event strategy and management – delivering locally tailored solutions and cutting-edge technologies to achieve
maximum results for venue owners. The company’s elite venue network spans five continents, with a portfolio
of more than 325 of the world’s most prestigious arenas, stadiums, convention and exhibition centers, and
performing arts venues. For more information, please visit www.asmglobal.com.
(Podcast produced by Johnny Kincaid)
INTRO COMMENTS WRITTEN BY STAFF
MAY 28, 2024
In this episode of This Week in Evansville, Johnny Kincaid expresses his disgust over the ongoing dysfunction in the Vanderburgh County Republican Party.
The most recent move by County Chairman Mike Duckworth was filing written complaints to the 8th District GOP Chair asking for the removal of three (3) duly elected precinct members (PCs) and state convention delegates. The complaints were filed four days after the county election board certified the results.
Kincaid says what Duckworth is doing is bad for the future of the local GOP in Vanderburgh County and the party leaders shouldn’t expect to win close elections until they stop the infighting.
Click the Podcast link posted below to hear what Johnny Kincaid has to say about the local GOP Chairman attempting to kick out three (3) recently elected PC party members.
CLICK HERE TO OPEN PODCAST
FOOTNOTE: The City-County Observer posted Mr. Kincaid’s podcast with the opinion that Mr. Duckworth should do the reasonable thing by dropping his baseless complaints against three (3) duly elected PC members of the Vanderburgh County GOP.
Please vote in the Readers’ POLL that asks the question how do you rate Mr> leadership style?
The new and improved bipartisan Promising Pathway Act will give patients with terminal diseases hope for new cures and treatments
Washington – Today, Senator Mike Braun, Senator Kirsten Gillibrand, and a bipartisan team of Senators introduced the new version of the Promising Pathway Act: a bill to give hope to thousands of Americans struggling with rare and life-threatening diseases.
When you’ve been diagnosed with a rare and progressive disease, access to promising treatments is the difference between life and death.
It takes about 6 years on average for a drug to get through the FDA’s fastest drug approval pathway – and even longer before patients can actually take them. Those with diseases like ALS simply don’t have time to wait.
That’s where Promising Pathway comes in. We’ll create a conditional approval pathway for drugs intended to treat rare, progressive and congenital diseases. Think of it like a “passing lane” for drugs that have shown safety and evidence of effectiveness for patients with life-threatening diseases who don’t have time to wait.
Promising Pathway has seen a groundswell of support from both sides of the aisle and the patient community in the past year. Over that time, Senator Braun’s team has put together changes to the bill to help it become law and better serve patients, resulting in today’s new version.
Promising Pathway 2.0 was introduced by Senator Mike Braun, Senator Kirsten Gillibrand, Senator Kevin Cramer, Senator Joe Manchin, Senator Eric Schmitt, Senator Alex Padilla, Senator J.D. Vance, Senator Cory Booker, Senator Josh Hawley, Senator Peter Welch, and Senator Lisa Murkowski.
NewsNation’s Kristen Eskow reported on the new version of the bill and spoke to some of the patients this legislation would help:
NewsNation | Bill would allow treatment for terminally ill before FDA approval
Here’s the bill text. The bill number will be S. 4426 to follow it on Congress.gov.
BELOW ARE LINKS CONCERNING THE BREAKDOWN OF THE DETAILS OF THE LAW
Here’s a look at some of the changes to the bill designed to help more patients and make the legislation a better candidate to become law.
Here’s a breakdown of what the bill does and how it will guarantee safety and efficacy.
THE CITY-COUNTY OBSERVER POSTED THIS ARTICLE WITHOUT OPINION BIAS OR EDITING.
New commitment brings the company’s total LEAP plans to $9 billion, with 900 new jobs, to support a current and future pipeline of medicines
INDIANAPOLIS – Today during the Indiana Global Economic Summit, Governor Eric J. Holcomb joined Eli Lilly and Company (NYSE: LLY) Chair and CEO David A. Ricks to announce Lilly’s plans to more than double its investment at the LEAP Research and Innovation District in Lebanon. The new $5.3 billion expansion brings Lilly’s total LEAP investment to $9 billion and will enhance Lilly’s capacity to manufacture active pharmaceutical ingredients (API) for its latest type 2 diabetes and obesity medicines.
“Lilly continues to play a transformational role in shaping Indiana’s opportunity economy, and I couldn’t be more proud about their pole position leadership in developing the LEAP Research and Innovation District in Lebanon, Indiana. Lilly has long been driving global innovation and economic growth that will be felt for decades here at home,” said Gov. Holcomb. “As an international company, headquartered in Indiana, Lilly had a world of options to consider before making this investment, and choosing Indiana once again reinforces the incredible environment we’ve cultivated and the talented workforce we have to carry Lilly’s success forward. I can’t wait to see the incredible benefits this investment leads to for patients around the world, knowing they were made in Indiana.”
In addition to the new, multi-billion-dollar investment, Lilly also committed to create another 200 new, full-time jobs for highly skilled workers, such as engineers, scientists, operating personnel and lab technicians, bringing the company’s total planned new jobs at LEAP to 900.
“Today’s announcement tops the largest manufacturing investment in our company’s history and, we believe, represents the single largest investment in synthetic medicine API manufacturing in U.S. history,” said Ricks. “This multi-site campus will make our latest medicines, support pipeline growth and leverage the latest technology and automation for maximum efficiency, safety and quality control. Importantly, we are investing in our home state of Indiana, creating high-wage, advanced manufacturing, engineering and science jobs for hundreds of current and future Hoosier families.”
Since 2020, Lilly has committed more than $16 billion to develop new manufacturing sites in the U.S. and Europe. New locations outside of Indiana include Research Triangle Park and Concord, North Carolina; Limerick, Ireland; and Alzey, Germany. Separately, Lilly has invested an additional $1.2 billion to update existing manufacturing facilities in Indianapolis. In May 2022, Lilly first announced its plans to invest $2.1 billion and create up to 500 new jobs at LEAP. At the company’s Lebanon groundbreaking in April 2023, Lilly announced an additional $1.6 billion investment and 200 new jobs at the site.
Since breaking ground at LEAP in April 2023, Lilly has transformed a significant portion of its 600 acres at the site into an active construction site and expects to begin making medicines there in late 2026.
The state has agreed to assist in developing a robust workforce ecosystem of qualified manufacturing talent by providing the land and helping to raise capital for a new workforce training center that will be part of the larger LEAP industrial development. The new training center will have added impact by aligning with Lilly’s previously announced financial support for scholarship and training programs with Purdue University and Ivy Tech Community College, as well as the BioCrossroads-led training center at 16 Tech – part of Indiana’s recent Tech Hub designation.
“We are excited about Eli Lilly and Company’s plan to expand their investment in Lebanon, reinforcing their role as a key community partner in driving future innovation and economic prosperity,” said Lebanon Mayor Matt Gentry. “Their investment underscores our shared commitment to creating greater opportunities and enhancing the quality of life for our residents and community.”
Based on the company’s plans to create 200 additional new jobs at their project site in LEAP, the IEDC committed an additional investment in Lilly of up to $500,000 in the form of incentive-based training grants. The IEDC also committed an additional investment of up to $20 million in redevelopment tax credits and $15 million in road infrastructure improvements based on the company’s announced plans to invest an additional $5.2 billion. Furthermore, with a total estimated capital investment of $9.7 billion and the hiring of 900 high-wage positions by Lilly at their LEAP site, the IEDC also revised its Innovation Development District award structure to accommodate a 30-year benefit period with an estimated value of $1.2 billion in tax rebates and the flexibility for the project to further grow. All incentives remain subject to the final IEDC Board of Directors and the state of Indiana required approvals and contracting.